OrthoPediatrics Corp.
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $70.5M | $59.4M | $61.6M | $61.3M | $61.1M | $52.4M | $52.7M | $54.6M |
| Cost of Revenue | $18.1M | $16.0M | $16.5M | $16.0M | $17.1M | $14.1M | $17.1M | $14.5M |
| Gross Profit | $52.4M | $43.4M | $45.1M | $45.3M | $44.0M | $38.3M | $35.6M | $40.1M |
| Gross Margin | 74.3% | 73.1% | 73.2% | 73.9% | 72.1% | 73.0% | 67.5% | 73.4% |
| Operating Expenses | ||||||||
| Research & Development | $2.3M | $2.2M | $2.3M | $2.3M | $2.2M | $2.4M | $2.9M | $2.6M |
| SG&A Expense | $32.8M | $31.0M | $30.0M | $29.2M | $30.4M | $30.3M | $24.4M | $26.3M |
| Operating Income | $-4.1M | $-8.3M | $-8.2M | $-9.4M | $-10.7M | $-11.0M | $-14.1M | $-5.6M |
| Operating Margin | -5.8% | -14.0% | -13.3% | -15.4% | -17.4% | -21.0% | -26.7% | -10.2% |
| Interest Expense | — | $1.7M | $-4.5M | $2.0M | $1.3M | $1.3M | $-1.7M | $945.0K |
| Pretax Income | $-6.9M | $-10.9M | $-9.8M | $-11.9M | $-7.1M | $-10.5M | $-16.4M | $-9.1M |
| Income Tax Expense | $234.0K | $-171.0K | $340.0K | $-125.0K | $49.0K | $196.0K | $-340.0K | $-1.2M |
| Net Income | $-7.2M | $-10.7M | $-10.1M | $-11.8M | $-7.1M | $-10.7M | $-16.1M | $-7.9M |
| Net Margin | -10.2% | -18.0% | -16.4% | -19.2% | -11.6% | -20.3% | -30.5% | -14.5% |
| EPS (Basic) | $-0.30 | $-0.45 | $-0.43 | $-0.50 | $-0.30 | $-0.46 | $-0.70 | $-0.34 |
| EPS (Diluted) | $-0.30 | $-0.45 | $-0.43 | $-0.50 | $-0.30 | $-0.46 | $-0.70 | $-0.34 |
| Shares Outstanding (Basic) | 24.0M | 23.7M | 23.5M | 23.6M | 23.5M | 23.2M | 23.1M | 23.2M |
| Shares Outstanding (Diluted) | 24.0M | 23.7M | 23.5M | 23.6M | 23.5M | 23.2M | 23.1M | 23.2M |
| Dividends Per Share | — | — | — | — | — | — | — | — |